HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer moves closer to H&R sale

This article was originally published in The Rose Sheet

Executive Summary

Fragrance and flavors supply business Haarmann & Reimer is expected to sell above current market expectations of $1.33 bil. (€1=$.88), Bayer says. Many competitors in the chemical industry have expressed interest in acquiring the division, Bayer adds. Among companies reportedly planning to bid for H&R are Swiss fragrance supplier Givaudan and German chemicals business Degussa. Although neither company would confirm their intentions, both say they are interested in future acquisitions. Bayer announced plans to sell Haarmann & Reimer in December as one of three divisions the company is shedding to focus on "core" businesses (11"The Rose Sheet" Dec. 10, 2001, p. 6)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel